DENVER, Jan. 3 -- US Medical Inc. has signed an exclusive agreement with Sunrise Technologies International Inc. of Fremont, Calif., to become the North American distributor of Sunrise Technologies' ophthalmic laser treatment for far sightedness (hyperopia).
US Medical gained the exclusive distribution rights to the Hyperion system, a holmium laser corneal shaping product and a process called Laser Thermal Keratoplasty, known as the Sunrise LTK Procedure, which received FDA approval in June 2000.
This strategic partnership with Sunrise Technologies further supports our company's mission: to improve the access, cost and quality of global health care, said Robert J. Lambrix, CEO of US Medical.